Literature DB >> 8648216

Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.

I Nakagawa1, I Takahashi, H Kiyono, J R McGhee, S Hamada.   

Abstract

The B subunit of heat-labile toxin (LT-B) from enterotoxigenic Escherichia coli has been shown to be a powerful mucosal immunogen. Oral immunization of mice with LT-B revealed that BALB/c (H-2d) and C57BL/6 (H-2b) mice gave high serum IgG and mucosal IgA responses specific for LT-B. However, ALY (H-2b) mice lacking intestinal Peyer's patches (PP) did not respond to oral LT-B with either serum or mucosal antibodies. These results indicate that PP lymphocytes supported both systemic and mucosal immune responses when the antigen was administered orally. Reverse transcription polymerase chain reaction analyses revealed that PP CD4 T cells expressed early Th1-type (interferon-gamma and interleukin [IL]-2) and late Th2-type (IL-4, -5, and -6) cytokine mRNA. These results suggest that the systemic and mucosal antibody responses induced by LT-B are regulated by a cooperation of PP Th1 and Th2 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648216     DOI: 10.1093/infdis/173.6.1428

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The identification of plant lectins with mucosal adjuvant activity.

Authors:  E C Lavelle; G Grant; A Pusztai; U Pfüller; D T O'Hagan
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

3.  Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.

Authors:  Jose Flores; Herbert L DuPont; Mercedes Paredes-Paredes; M Magdalena Aguirre-Garcia; Araceli Rojas; Alexei Gonzalez; Pablo C Okhuysen
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

4.  Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.

Authors:  Hong-Duck Kim; Kazuki Tahara; J Adam Maxwell; Robert Lalonde; Tatsuya Fukuiwa; Kohtaro Fujihashi; Kent R Van Kampen; Fan-Kun Kong; De-chu C Tang; Ken-ichiro Fukuchi
Journal:  J Gene Med       Date:  2007-02       Impact factor: 4.565

5.  Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.

Authors:  G Douce; M Fontana; M Pizza; R Rappuoli; G Dougan
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

6.  Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice.

Authors:  N Tsuji; K Suzuki; H Kasuga-Aoki; Y Matsumoto; T Arakawa; K Ishiwata; T Isobe
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

7.  Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.

Authors:  Kurt Z Long; Jorge L Rosado; José Ignacio Santos; Meredith Haas; Abdullah Al Mamun; Herbert L DuPont; Nanda N Nanthakumar; Teresa Estrada-Garcia
Journal:  Infect Immun       Date:  2009-12-28       Impact factor: 3.441

8.  Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.

Authors:  S Ricci; D Medaglini; C M Rush; A Marcello; S Peppoloni; R Manganelli; G Palú; G Pozzi
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

9.  Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.

Authors:  D G Millar; T R Hirst; D P Snider
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

10.  Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.

Authors:  Ignazio Castagliuolo; Marina Sardina; Paola Brun; Chiara DeRos; Cristina Mastrotto; Laura Lovato; Giorgio Palù
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.